# A Study to Evaluate the Differences in Pharmadynamics, Pharmacokinetics, and Safety Between Ciprofol and Propofol

> **NCT04294056** · PHASE1 · COMPLETED · sponsor: **Haisco Pharmaceutical Group Co., Ltd.** · enrollment: 18 (actual)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Ciprofol
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT04294056
- **Lead sponsor:** Haisco Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-26
- **Primary completion:** 2020-06-22
- **Final completion:** 2020-09-18
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04294056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04294056, "A Study to Evaluate the Differences in Pharmadynamics, Pharmacokinetics, and Safety Between Ciprofol and Propofol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04294056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*